Correlation Between Tscan Therapeutics and Arrowhead Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Arrowhead Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Arrowhead Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Arrowhead Pharmaceuticals, you can compare the effects of market volatilities on Tscan Therapeutics and Arrowhead Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Arrowhead Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Arrowhead Pharmaceuticals.

Diversification Opportunities for Tscan Therapeutics and Arrowhead Pharmaceuticals

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Tscan and Arrowhead is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Arrowhead Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arrowhead Pharmaceuticals and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Arrowhead Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arrowhead Pharmaceuticals has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Arrowhead Pharmaceuticals go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and Arrowhead Pharmaceuticals

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the Arrowhead Pharmaceuticals. In addition to that, Tscan Therapeutics is 1.07 times more volatile than Arrowhead Pharmaceuticals. It trades about -0.13 of its total potential returns per unit of risk. Arrowhead Pharmaceuticals is currently generating about -0.01 per unit of volatility. If you would invest  2,291  in Arrowhead Pharmaceuticals on November 2, 2024 and sell it today you would lose (268.00) from holding Arrowhead Pharmaceuticals or give up 11.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tscan Therapeutics  vs.  Arrowhead Pharmaceuticals

 Performance 
       Timeline  
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Arrowhead Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Arrowhead Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Tscan Therapeutics and Arrowhead Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tscan Therapeutics and Arrowhead Pharmaceuticals

The main advantage of trading using opposite Tscan Therapeutics and Arrowhead Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Arrowhead Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will offset losses from the drop in Arrowhead Pharmaceuticals' long position.
The idea behind Tscan Therapeutics and Arrowhead Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios